our north star

Imagine a world where the body’s own defenses are fine-tuned, on demand, to seek out and eliminate disease—no harsh preconditioning, no months-long cell manufacturing, just a swift, targeted intervention that adapts to each patient. At Enparis Bio, we’re turning that vision into reality. Born at the Punjab Bio-Technology Incubator in Mohali, our journey began with a conviction: that modular mRNA technologies can democratize cutting-edge immunotherapies and cancer vaccines, making them safe, scalable, and deeply relevant to populations in India and beyond.

Our cell therapy expertise allows us to engineer cells to target and treat a range of diseases, including cancer, autoimmune disorders, and more.